IVRAFERAV Trademark

Trademark Overview

On Thursday, October 19, 2023, a trademark application was filed for IVRAFERAV with the United States Patent and Trademark Office. The USPTO has given the IVRAFERAV trademark a serial number of 98230485. The federal status of this trademark filing is NOTICE OF ALLOWANCE - ISSUED as of Tuesday, September 3, 2024. This trademark is owned by IMMVIRA CO., LIMITED. The IVRAFERAV trademark is filed in the Pharmaceutical Products category with the following description:

Antiseptics; Biological preparations for the treatment of cancer; Human vaccine preparations; Immunostimulants; Medicinal preparations for the treatment of infectious diseases and for use in oncology; Oral vaccine preparations; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical preparations for the treatment of immune system related diseases and disorders; Pharmaceutical preparations for the treatment of viral diseases; Pharmaceutical preparations for the treatment of viral infections; Pharmaceutical preparations, namely, antivirals; Vaccine preparations; Vaccines; Viral vaccines
ivraferav

General Information

Serial Number98230485
Word MarkIVRAFERAV
Filing DateThursday, October 19, 2023
Status688 - NOTICE OF ALLOWANCE - ISSUED
Status DateTuesday, September 3, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, July 9, 2024

Trademark Statements

Goods and ServicesAntiseptics; Biological preparations for the treatment of cancer; Human vaccine preparations; Immunostimulants; Medicinal preparations for the treatment of infectious diseases and for use in oncology; Oral vaccine preparations; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical preparations for the treatment of immune system related diseases and disorders; Pharmaceutical preparations for the treatment of viral diseases; Pharmaceutical preparations for the treatment of viral infections; Pharmaceutical preparations, namely, antivirals; Vaccine preparations; Vaccines; Viral vaccines

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, October 19, 2023
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameIMMVIRA CO., LIMITED
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressLonghua Dist.,Shenzhen 518110
CN
Party NameIMMVIRA CO., LIMITED
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressLonghua Dist.,Shenzhen 518110
CN

Trademark Events

Event DateEvent Description
Thursday, October 19, 2023NEW APPLICATION ENTERED
Sunday, January 7, 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, June 4, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, June 4, 2024ASSIGNED TO EXAMINER
Wednesday, June 19, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, July 9, 2024PUBLISHED FOR OPPOSITION
Tuesday, July 9, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, September 3, 2024NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Sunday, January 7, 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Related Keywords

ivraferav preparations treatment pharmaceutical diseases viral vaccine immune related system disorders